Secondly, only the mechanism of the USP7/p300 pathway of EPCs treatment in COPD has been studied, and more potential mechanisms of EPCs therapy in COPD have not been thoroughly explored. This evidence concerns the gene USP7 and chronic obstructive pulmonary disease.